Compare Alcon AG (ALC) vs Roundhill Innov-100 0DTE Covered Call Strat ETF (QDTE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alcon AG vs Roundhill Innov-100 0DTE Covered Call Strat ETF — how do they compare? Alcon AG trades at $73.45 (market cap $35.29B), while Roundhill Innov-100 0DTE Covered Call Strat ETF trades at $29.87. The key difference: Alcon AG pays a 0.49% dividend while Roundhill Innov-100 0DTE Covered Call Strat ETF pays none. Which is the better fit depends on your goals.
| ALC | QDTE | |
|---|---|---|
Market Cap | $35.29B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $90.12 | $36.60 |
52-Week Low | $62.02 | $26.85 |
Enterprise Value | $39.13B | — |
Dividend Yield | 0.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $73.52, down 2.43% on the day, with a bullish technical signal from moving averages. Recent Q2 2026 earnings beat estimates, and the company raised its 2026 profitability outlook. Revenue growth is steady, reaching $10.40B in 2025, though net income margin dipped to 5.92%. The stock is supported by strong analyst consensus, with a price target of $85.85.
Outlook is positive due to earnings beats and raised guidance, but high P/E of 56.17 poses valuation risk. Competition and margin pressures are key concerns. Institutional interest is rising, with Bill Ackman's new position noted in August 2026 news.
QDTE trades at $29.80, up 0.85% in the last session, but technical indicators signal a bearish trend with selling pressure outweighing buying signals. The fund's high distribution yield of 24% is noted to be funded by return of capital, leading to NAV erosion, as highlighted by Seeking Alpha on August 10, 2026. Recent corporate actions include multiple dividend payments, but financial ratios like P/E and P/S are unavailable, limiting fundamental assessment.
The outlook for QDTE is cautious due to structural risks from its yield strategy, which may impair long-term value. Investment opportunities are limited given the bearish sentiment and lack of positive earnings metrics. Key risks include continued NAV decline and underperformance in rising markets, warranting careful evaluation for income-focused investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Roundhill Innov-100 0DTE Covered Call Strat ETF
QDTE is an actively managed ETF that seeks to generate income through a covered call strategy on the NASDAQ 100. It primarily holds a portfolio of U.S. government securities and sells 0-DTE (zero days to expiration) index call options on the NASDAQ 100. This highly tactical strategy aims to maximize option premium capture by exploiting the rapid time decay of options expiring on the same day, which provides enhanced income but also exposes the fund to significant volatility and risks associated with daily options settlement.
Read more on QDTE →
